Duopharma Biotech Berhad (7148.KL) reported earnings for its first quarter that Increased, from the same period last year
The company's bottom line totaled MYR30.71 million, or MYR0.0319 per share. This compares with MYR25.64 million, or MYR0.0267 per share, last year.
The company's revenue for the period fell 5.7% to MYR247.88 million from MYR262.74 million last year.
Duopharma Biotech Berhad earnings at a glance (GAAP) :
-Earnings: MYR30.71 Mln. vs. MYR25.64 Mln. last year.-EPS: MYR0.0319 vs. MYR0.0267 last year.-Revenue: MYR247.88 Mln vs. MYR262.74 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.